ESCMID is led by the Executive Committee (EC), a diverse group of Clinical Microbiology (CM) and Infectious Disease (ID) specialists. The EC is supported by subcommittees, made up of ESCMID members, who play an important role in fostering excellence within the Society. ESCMID is organised in accordance with the Articles of Association and Bylaws that dictate the established Policies & Laws.
The dedicated ESCMID Executive Committee (EC) and ad hoc members are the driving force behind everything ESCMID does. Together, they embody the leadership of the Society, upholding ESCMID's mission and vision with a collective commitment to excellence. EC and ad hoc members come from a variety of countries and background and have all made significant contributions to ESCMID, with a minimum active involvement of three years. The EC consists of eight voting members, each bringing a distinct blend of skills, expertise, and passion, enriching the collective efforts and guiding the Society forward. Get to know the individuals behind ESCMID!
We are pleased to announce that Jan Kluytmans from Utrecht, Netherlands, will join the ESCMID Executive Committee in April 2025 as representative of Clinical Microbiology (CM)
The Education Subcommittee shapes ESCMID’s education portfolio and structure. It emphasises the importance of sharing knowledge and promoting professional growth in CM and ID.
The Scientific Affairs Subcommittee guides the Society on matters related to cutting-edge research and publications in Clinical Microbiology (CM) and Infectious Diseases (ID). This subcommittee directly supports the Scientific Affairs Officer, ensuring ESCMID is at the forefront of innovation.
The Professional Affairs Subcommittee advises ESCMID on strategic professional development matters, including training, observerships, and mentorships. They also collaborate with global partners and represent ESCMID internationally.
The ESCMID AMR Action Subcommittee supports and develops antimicrobial resistance (AMR)-specific content across ESCMID’s portfolio. They are also the driving force behind the coordination and promotion of all AMR-related activities to key stakeholders.
After the COVID-19 pandemic, a major priority for ESCMID is preparedness and response to Emerging Infectious Diseases (EID). The ESCMID Emerging Infections Subcommittee was formed to create strategies that monitor, guide, educate and develop research in EIDs.
The Publication Subcommittee plays a crucial role in expanding and disseminating ESCMID’s knowledge and best practices worldwide through the Society’s journals, Clinical Microbiology and Infection (CMI) and CMI Communications. Through their contribution, these dedicated individuals play an important role in advancing ESCMID's commitment to excellence in both research and clinical practice.
ESCMID guidelines are developed by the Guidelines Subcommittee and are assembled through the latest independent research in ID, CM and Infection Control (IC). ESCMID’s dedicated team ensures that evidence appraisal and data extraction adhere to strict procedures while providing reliable and up-to-date guidance.
The Parity Commission advocates for diversity in ESCMID’s activities. This subcommittee reviews and improves the representation of genders and minority groups. It also ensures geographic balance in CM and ID by creating opportunities for, and helping to amplify, the contributions of these members.
The ESCMID Ethical Advisory Committee (EEAC) is an independent body that advises the EC on specific ethical, regulatory, social, and philosophical issues related to ESCMID-funded research projects or members. The EEAC has no authority to make final decisions or put policies into action without the approval of the EC.